South Dakota Investment Council Corcept Therapeutics Inc Transaction History

South Dakota Investment Council

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$17.1 - $23.34 $4,702 - $6,418	-275 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$19.68 - $22.53 $308,976 - $353,721	-15,700 Reduced 98.28%	275 $5,000
Q2 2021 Aug 11, 2021	SELL	$19.97 - $24.43 $311,532 - $381,108	-15,600 Reduced 49.41%	15,975 $351,000
Q1 2021 May 13, 2021	BUY	$23.49 - $30.56 $6,459 - $8,404	275 Added 0.88%	31,575 $751,000
Q3 2020 Nov 06, 2020	SELL	$12.46 - $19.98 $183,162 - $293,706	-14,700 Reduced 31.96%	31,300 $545,000
Q2 2020 Aug 13, 2020	SELL	$11.0 - $18.26 $81,400 - $135,124	-7,400 Reduced 13.86%	46,000 $774,000
Q3 2019 Nov 13, 2019	BUY	$10.41 - $14.66 $91,608 - $129,008	8,800 Added 19.73%	53,400 $755,000
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $547,242 - $697,990	44,600 New	44,600 $625,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.